Pediatrix Medical (MD) Depreciation & Amortization (CF) (2009 - 2026)

Pediatrix Medical (MD) has reported Depreciation & Amortization (CF) for 18 consecutive years, with $6.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 14.76% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $22.6 million (down 17.01% YoY), while the FY2025 annual figure was $21.8 million, down 32.27% from the prior year.
• Depreciation & Amortization (CF) advanced to $6.1 million in Q1 2026 per MD's latest filing, from $5.6 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $10.3 million in Q1 2024 and bottomed at $5.3 million in Q2 2025.
• Historically, Depreciation & Amortization (CF) has averaged $7.8 million across 5 years, with a median of $8.8 million in 2022.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) climbed 16.25% — and 2025, when it plunged 48.27%.
• Pediatrix Medical's Depreciation & Amortization (CF) stood at $9.1 million in 2022, then fell by 0.81% to $9.1 million in 2023, then decreased by 24.16% to $6.9 million in 2024, then declined by 18.07% to $5.6 million in 2025, then advanced by 8.67% to $6.1 million in 2026.
• Business Quant data shows MD's Depreciation & Amortization (CF) at $6.1 million in Q1 2026, $5.6 million in Q4 2025, and $5.6 million in Q3 2025.